Redcare Pharmacy NV Cash Flow Conversion Efficiency

Latest as of March 2026: 0.044x

Redcare Pharmacy NV cash flow conversion efficiency. Based on the latest financial reports, Redcare Pharmacy NV (RDC) has a cash flow conversion efficiency ratio of 0.044x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€20.70 Million ≈ $24.20 Million USD) by net assets (€468.30 Million ≈ $547.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Redcare Pharmacy NV (2013–2025)

Cash flow conversion efficiency of Redcare Pharmacy NV from 2013 to 2025. This chart illustrates how Redcare Pharmacy NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. View RDC stock price and chart for real-time trading data and today's change.

Redcare Pharmacy NV Cash Flow Conversion Ratio Explained

Redcare Pharmacy NV cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Redcare Pharmacy NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Redcare Pharmacy NV ranked by their cash flow conversion efficiency. Also see Redcare Pharmacy NV market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Guangdong Shenglu Telecommunication Tech Co Ltd SHE:002446	-0.007x
Net263 Ltd SHE:002467	0.018x
Jiangsu Chengxing Phosph-Chemical Co Ltd SHG:600078	0.150x
Hubei Chutian Expressway Co Ltd SHG:600035	0.036x
LGI Homes NASDAQ:LGIH	0.041x
Algoma Central Corporation TO:ALC	0.030x
Hotel Shilla KO:008770	-0.137x
First Community Bancshares Inc NASDAQ:FCBC	0.035x

Annual Cash Flow Conversion Efficiency for Redcare Pharmacy NV (2013–2025)

The table below shows the annual cash flow conversion efficiency of Redcare Pharmacy NV from 2013 to 2025. Review RDC free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€479.20 Million ≈ $560.24 Million	€23.00 Million ≈ $26.89 Million	0.048x	+10.62%
2024-12-31	€509.97 Million ≈ $596.21 Million	€22.13 Million ≈ $25.87 Million	0.043x	-61.03%
2023-12-31	€552.03 Million ≈ $645.38 Million	€61.46 Million ≈ $71.85 Million	0.111x	+235.61%
2022-12-31	€354.63 Million ≈ $414.60 Million	€-29.11 Million ≈ $-34.03 Million	-0.082x	-393.10%
2021-12-31	€415.41 Million ≈ $485.66 Million	€11.63 Million ≈ $13.60 Million	0.028x	-33.11%
2020-12-31	€425.14 Million ≈ $497.03 Million	€17.80 Million ≈ $20.81 Million	0.042x	+132.10%
2019-12-31	€232.76 Million ≈ $272.12 Million	€-30.37 Million ≈ $-35.50 Million	-0.130x	-18.58%
2018-12-31	€213.98 Million ≈ $250.16 Million	€-23.54 Million ≈ $-27.52 Million	-0.110x	-13.11%
2017-12-31	€238.97 Million ≈ $279.38 Million	€-23.24 Million ≈ $-27.17 Million	-0.097x	+47.26%
2016-12-31	€93.25 Million ≈ $109.01 Million	€-17.20 Million ≈ $-20.11 Million	-0.184x	+94.83%
2015-12-31	€2.46 Million ≈ $2.87 Million	€-8.78 Million ≈ $-10.26 Million	-3.570x	-1844.15%
2014-12-31	€20.06 Million ≈ $23.45 Million	€-3.68 Million ≈ $-4.31 Million	-0.184x	+21.73%
2013-12-31	€18.08 Million ≈ $21.14 Million	€-4.24 Million ≈ $-4.96 Million	-0.235x	--

About Redcare Pharmacy NV

XETRA:RDC Germany Pharmaceutical Retailers

Market Cap

$1.80 Billion

€1.54 Billion EUR

Market Cap Rank

#9022 Global

#1158 in Germany

Share Price

€75.90

Change (1 day)

+9.05%

52-Week Range

€30.86 - €79.25

All Time High

€246.00